Every year on 20 May, the global clinical research community observes International Clinical Trials Day, a moment to recognize the scientific progress, collaboration, and patient participation that make medical advancement possible. At Lambda Therapeutic Research, this day is an opportunity to reflect on our journey in clinical research and the responsibility that comes with contributing to global healthcare development.
The Beginning of Modern Clinical Trials
International Clinical Trials Day commemorates the date in 1747 when James Lind, a surgeon in the British Royal Navy, conducted one of the earliest documented controlled clinical trials. His study focused on scurvy, a disease that affected sailors during long sea voyages.
Lind evaluated multiple treatment approaches among 12 sailors. The group receiving citrus fruits showed clear improvement, establishing one of the earliest examples of evidence-based medical intervention. Although the sample size was small, the findings eventually transformed naval healthcare practices and demonstrated the importance of systematic clinical evaluation.
The significance of Lind’s work extends beyond the discovery itself. The study faced skepticism, adoption was slow, and acceptance took years. The story remains relevant today because clinical research continues to require scientific rigor, careful interpretation of data, regulatory oversight, and persistence.
Lambda and Novum: Decades of Global Clinical Research Experience
Established in 1999 in Ahmedabad, India, Lambda Therapeutic Research began with a focused objective to provide high-quality clinical research services with scientific accuracy, operational efficiency, and regulatory compliance. Over the last 25 years, Lambda has expanded into a global CRO with operations across India, the USA, Canada, the UK, Spain, and Poland.
A major milestone came in 2019 with the acquisition of Novum Pharmaceutical Research Services, a North American CRO with over five decades of experience. This strengthened Lambda’s early-phase expertise and expanded its ability to support pharmaceutical, biotech, and generic drug development programs through a global full-service platform.
Today, Lambda and Novum together have enrolled more than 80,000 participants across 290+ clinical trials spanning over 15 therapeutic areas. The organization has supported submissions to major global regulatory agencies including the US FDA, EMA, DCGI, and ANVISA.
Lambda and Novum has conducted more than 8,500 BA/BE studies aligned with global regulatory requirements. Capabilities across clinical operations, bioanalytical services, data management, pharmacovigilance, medical writing, regulatory affairs, and laboratory services support efficient study execution from initiation to final reporting.
Built on Regulatory Compliance and Quality
In clinical research, quality and compliance directly influence data integrity and patient safety. Over the past five years, Lambda has successfully undergone more than 60 international inspections and audits conducted by regulatory authorities including the US FDA, EMA, MHRA, and other global agencies.
This consistency is supported by continuous investment in scientific expertise, operational systems, digital infrastructure, and quality processes.
In 2023, Lambda received the Regulatory & Compliance Excellence Award at the CPHI Pharma Awards for advancing compliance and clinical data generation through integrated software and EDC solutions. During the same year, Lambda was also recognized as Industry Partner of the Year at the Global Generics & Biosimilars Awards. In addition, Lambda has been recognized among the Top 10 Contract Research Organizations by Industry Outlook and was previously awarded Best Indian CRO by Frost & Sullivan.
Lambda-Novum Advantage
oday, Lambda provides integrated CRO and CDMO services to innovator, biotech, and generic pharmaceutical companies worldwide. In addition to comprehensive clinical research capabilities across Phase I to Phase IV, Lambda is expanding its CDMO biologics development capabilities to support biologics, biosimilars, and other complex therapeutic programs through a more integrated development approach.
With operations across India, North America, and Europe, Lambda supports global clinical development programs with region-specific regulatory understanding and operational flexibility.
1. Proven Therapeutic Expertise
- Oncology & Hematology
- Dermatology
- Neuroscience
- Biosimilar Development
- Infectious Disease
- Pulmonology
- Cardiovascular & Metabolic disorder
- Gastroenterology
- Nephrology
- Ophthalmology
- Musculoskeletal
- Cross-Therapeutic – Women’s Health, Pediatrics, Nutricaeuticals, Cosmetic Products.
2. Comprehensive CRO Services
Lambda provides support across the clinical development lifecycle, helping sponsors streamline operations, improve coordination, and maintain data consistency across programs.
- Early development and innovation
- Phase II-IV Clinical Trial Management
- Clinical Development Services (CDS) Project Management
- Regulatory Affairs
- Medical Writing
- CDMO Services
- Biostatistics & Data Management
- Medical Affairs
- Clinical Safety & Pharmacovigilance
- Medical Imaging
- eTMF
- Technology
- Laboratory – Bioanalytical, Bioanalytical and Clinical Labs
3. Regulatory and Quality Compliance
Regulatory alignment and quality assurance are central to every clinical development program supported by Lambda. Operations are aligned with international standards including Good Clinical Practice (GCP), Good Laboratory Practice (GLP), and ICH guidelines.
The quality framework includes internal audits, SOP harmonization across geographies, and processes aligned with global regulatory expectations. Lambda has supported inspections and submissions across health authorities including the FDA, EMA, Health Canada, MHRA, and CDSCO.
4. Purpose-Built Solutions for Every Project
No two clinical programs are the same. That’s why we design solutions around the specific goals, timelines, and regulatory requirements of each project. At Lambda, our operational flexibility allows us to adapt study designs, delivery models, and team structures to match the unique needs of every sponsor.
Trusted by biotech and pharmaceutical companies globally, we bring a practical, responsive approach that supports more efficient execution, stronger oversight, and outcomes aligned with both clinical and regulatory expectations.
Recognizing the People Behind Clinical Research
Clinical trials are made possible through collaboration between researchers, clinicians, volunteers, patients, data managers, regulatory specialists, and operational teams.
On International Clinical Trials Day, we acknowledge and thank every participant, investigator, healthcare professional, and research team member who contributes to clinical development programs at Lambda and Novum.
Every clinical trial contributes to the development of safer and more effective therapies. The progress achieved through clinical research ultimately improves patient care and expands treatment possibilities for future generations.
Looking Ahead
Clinical trials play a critical role in transforming scientific research into approved therapies that improve patient outcomes. As drug development becomes increasingly complex and globally regulated, sponsors require partners with scientific expertise, operational scale, and regulatory understanding across regions.
At Lambda Therapeutic Research, we continue to strengthen our capabilities across clinical research and CDMO biologics development to support evolving pharmaceutical and biotech programs worldwide. With over two decades of experience, our focus remains on enabling efficient study execution, reliable data generation, and long-term development partnerships across the clinical lifecycle.
